Johnson & Johnson’s legal maneuvering

Johnson & Johnson is facing two multibillion-dollar threats from court cases related to its role in the opioid epidemic and allegations its baby powder contained asbestos. To contend with the liabilities, the company is deploying legal tactics used in bankruptcy cases, including a relatively rare type of merger. Axios Re:Cap host Felix Salmon is joined by David Warfield, a partner at Thompson Coburn and a bankruptcy expert, to unpack exactly what Johnson & Johnson’s latest moves mean for these court cases and bankruptcy law at large.

Om Podcasten

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app.  Axios Re:Cap is on hiatus until October 2021.